|
HS Code |
960258 |
As an accredited 5-Chloro-2-Fluorobenzyl Bromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Chloro-2-Fluorobenzyl Bromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of organic chemistry, small changes in structure can spark big changes in function. Among the wide variety of benzyl bromide derivatives out there, 5-Chloro-2-Fluorobenzyl Bromide stands out. Known for its precise halogenation, this unique compound reshapes how labs and production facilities tackle synthesis projects that call for selectivity and reactivity.
This organic intermediate combines a bromide, a chlorine atom, and a fluorine atom on a single benzyl ring. Here, these halogens do more than just decorate the molecule—they fine-tune its behavior, raise its reactivity profile, and create new avenues for complex molecule construction. Across many areas—medicinal chemistry, agricultural research, material science—these features make all the difference. This isn’t just another brominated compound. In my work with functionalized benzylic molecules, I’ve seen first-hand how a well-placed halogen can flip the switch from “average starting material” to “must-have building block.”
Most reputable labs and chemical firms supply 5-Chloro-2-Fluorobenzyl Bromide in purity levels tailored for demanding research and commercial projects. Researchers typically look for colorless to pale yellow oily liquids, with specifications checked by NMR and mass spectrometry. Molecular formula: C7H5BrClF. Molar mass: about 225.47 g/mol. Density approaches 1.6 g/cm3 at room temperature. Boiling points and melting points can vary depending on slight shifts in crystalline form—a reminder that even simple molecules can behave unpredictably. If you’ve ever worked with halogenated benzylic bromides, you know that purity matters. Even a touch of isomeric impurity or leftover solvents will throw off your downstream chemistry. Every reliable supplier performs HPLC or GC analysis to assure buyers the material meets tight purity guidelines.
What makes this compound reliable for synthesis is not just its analytical profile. Handling is straightforward, with typical storage under dry, cool, and dark conditions—much like other benzylic bromides. In my lab, that often meant labeling it with a bright sticker to warn students: reactive alkyl bromides demand respect, especially when heating is involved.
The distinctive placement of chlorine and fluorine atoms in this molecule’s benzene ring isn’t just a quirk in structure. It shapes how the molecule interacts with nucleophiles, how it fits in with other intermediates, and even what downstream products are reachable. In medicinal chemistry projects, adding one fluorine can shift metabolic stability, increase binding selectivity, and unlock new interactions with biological targets. Add a chlorine atom, and you can further refine the molecular properties—controlling lipophilicity, influencing solubility, and steering subsequent transformations.
These subtle tweaks cannot be replicated by using generic benzyl bromides. Let me use an example. Say you’re building a library of drug analogs for a fluorinated benzyl scaffold. If you swap the position of the halogens—putting chlorine ortho instead of meta, flipping fluorine to the para position—you end up with a molecule that acts differently in every test, from reactivity to biological evaluation. Looking back at synthetic campaigns I’ve supported, more than once a stalled SAR project broke through after we brought in compounds like this one—halogenated in just the right way on the benzylic ring.
Not all halogenated benzyl bromides offer this same level of versatility. 4-chlorobenzyl bromide often serves as a quick fix, but it doesn’t open the same doors for structure–activity exploration or agrochemical innovation. Many benzylic halides lack fluorination altogether, restricting their downstream utility. Modern pharma demands new motifs for pushing patent space or tweaking ADME profiles, so fluorination remains precious. Any chemist who has tried to introduce fluorine late in synthesis—or struggled against the lethargy of a mono-halogenated benzyl intermediate—will tell you: pre-installed halogenation isn’t just a luxury, it’s a competitive edge.
This compound’s major value lies in its role as a starting material or a coupling partner for more complex structures. In medicinal chemistry, the fluorine’s electron-withdrawing power keeps metabolic oxidation at bay, helping lead compounds evade breakdown by liver enzymes. Chlorine, meanwhile, boosts receptor affinity or blocks sites of undesired reactivity. The net result? Researchers get a molecule with better downstream prospects—higher potency, less rapid metabolism, and fewer off-target effects. If you’re designing kinase inhibitors, anti-inflammatory agents, or even PET imaging probes, starting from 5-Chloro-2-Fluorobenzyl Bromide can prune weeks from your discovery cycle.
This isn’t pure speculation—numerous published studies cite this benzyl bromide as a key intermediate. Take the synthesis of certain anti-cancer fluorinated benzylamines or the creation of specialty agrochemicals targeting resistant pests. Material scientists use it for modifying polymers, taking advantage of the C–F and C–Cl bonds to introduce chemical stability or fine-tune dielectric properties. Even outside high-tech sectors, custom fragrance and flavor companies will occasionally select a rare benzyl halide for a bold scent profile. The compound’s ability to take a standard benzyl structure and electrify it—literally, through halogen effects—makes it an ally for creative synthesis.
Some may still wonder why anyone should bother with an intermediate like this, instead of sticking to cheaper, more common benzyl bromides or relying on late-stage halogenation. My experience working on both early discovery and process scale-up highlights one fact: targeted halogenation delivers results that scattershot chemistry can’t. When you try to halogenate a finished molecule, you often end up playing whack-a-mole with unintended byproducts, inconsistent yields, and challenging purifications.
Buying or synthesizing a molecule with halogens in the right place, on the other hand, brings reliability to every step. The pharmaceutical sector is under growing pressure to prove synthetic routes are robust, safe, and cost-effective. Regulators look for clean impurity profiles and well-understood degradation products. 5-Chloro-2-Fluorobenzyl Bromide, with its defined configuration, can make life easier for the teams downstream. By starting with purpose-built intermediates, chemists avoid headaches and sidestep the time and money cost of late-stage structure modification.
No one in the lab should underestimate the risks of handling benzyl bromides, and this version—with both chloro and fluoro substituents—calls for particular care. Skin sensitization, mucous membrane irritation, and potential for long-term exposure issues are real. Gloves, goggles, fume hoods—non-negotiable. In my time teaching advanced synthesis, I made it a policy to walk through each handling step with students, not because such precautions slow down the work, but because a single exposure can sideline a project for weeks.
From an environmental perspective, the presence of halogens raises flags about persistence and bioaccumulation. Disposal routes must align with local and federal guidelines. Large-scale synthetic campaigns increasingly look beyond mere regulatory compliance, exploring green chemistry routes to minimize waste. Some initiatives target milder bromination methods or investigate recyclable solvents and catalysts.
I’ve worked at places where sustainable practices seemed like an afterthought and at others where every waste drum was scrutinized for optimization. Labs today should aim for the latter. The right supplier for this compound won’t just focus on purity—they’ll provide documentation on environmental management and compliance with the latest hazard communication standards.
Let’s cut through the marketing noise around “premium” or “tailored” chemical products. What really sets 5-Chloro-2-Fluorobenzyl Bromide apart isn’t an abstract promise. It’s the compound’s ability to keep reactivity under tight control and deliver results every time. There’s a good reason it’s gaining traction among synthetic chemists: it consistently outperforms single-halide counterparts in yield and selectivity, particularly in nucleophilic substitutions or cross-coupling chemistry.
What you won’t find in every data sheet or spec list is how it can sometimes simplify route scouting. For example, I once saw a process chemist swap out a less reactive benzyl bromide for this one. The result was a 30 percent uptick in overall yield and elimination of an unwanted dehalogenated impurity. Real-world experience confirms the compound’s unique configuration actually delivers measurable improvements.
In my experience, sourcing sensitive intermediates like 5-Chloro-2-Fluorobenzyl Bromide calls for more than just checking the lowest price on a catalogue. Consistency can make or break a project; an unreliable batch with mystery impurities can throw timelines off, introduce safety incidents, or even force a complete revalidation with regulatory agencies. Trustworthy suppliers do more than ship the chemical—they share batch certificates, answer technical queries promptly, and have protocols in place for quick response if anything goes wrong. Labs that cut corners here tend to pay the price later—in lost productivity, wasted raw materials, or failed product launches.
Within larger research organizations, procurement officers now cross-check suppliers against a list of environmental, social, and governance criteria. This isn’t just about corporate responsibility—it’s about protecting the investment in R&D. When you spend weeks building a synthetic sequence, you want assurances the building blocks perform, every time. A single subpar batch, containing extra water or misassigned halide ratios, can derail progress and sow distrust between chemists and their supply chain partners. It’s worth taking the time to build relationships with suppliers whose track records speak for themselves.
Not every lab or company can afford to keep a full stock of rare intermediates. That reality poses a challenge: should chemists invest in custom synthesis, stockpile key reagents, or take the risk of on-demand procurement? Each approach comes with trade-offs. Large pharmaceutical companies may opt for partnerships with contract manufacturers who scale up to kilogram-level batches. Academic labs might pool resources or join collaborative purchasing agreements to secure affordable access.
Some newer chemical marketplaces now use transparent sourcing and third-party testing data to ensure you really get what’s promised. In my view, the rise of distributed digital platforms with independent verification may do more to improve lab safety and productivity than top-down regulation ever could.
Then there’s the intellectual property dimension. Novel intermediates like this sometimes sit at the center of patent battles or restrict freedom to operate. Navigating these waters takes as much creativity and attention to detail as synthetic planning itself.
One recurring challenge with halogenated benzyl bromides relates to regioselective substitution—getting the right isomer without a mess of side products. Chemists have pushed the boundaries with newer catalysts and milder conditions in the past decade. I’ve seen hydrogenation strategies and catalytic borylation methods cut reaction times in half, boost yields, and trim purification headaches. Many teams are eager to develop “off-the-shelf” aryl halides that fit directly into metal-catalyzed cross-coupling toolkits—Suzuki, Buchwald-Hartwig, Negishi—without the need for lengthy pre-activation or protecting group games.
Expanding access to 5-Chloro-2-Fluorobenzyl Bromide could open doors in quickly growing fields like radiolabeling, polymer modification, and targeted molecular imaging. If suppliers keep pace with demand for research-grade and GMP-quality material, future advances in drug development and specialty chemicals will become easier to realize.
Researchers willing to innovate around this intermediate are likely to unlock not just better synthetic shortcuts, but also unexpected biological properties. In fields where milligrams of a new compound can represent a scientific breakthrough, access to rare building blocks gives one lab an edge over another.
After years in the field, I see 5-Chloro-2-Fluorobenzyl Bromide as the kind of compound that rewards deep understanding. It isn’t just a reagent to be checked off a list; it’s a strategic choice that can make or break complex synthesis routes. The subtle balance of chlorine and fluorine, lined up in just the right places on the benzyl ring, delivers options you can’t always predict. Striking the right balance—sourcing, safety, sustainability, and cost—remains the biggest challenge, but also the biggest opportunity for teams that are pushing chemical progress.
Chemists driven to produce safer drugs, more sustainable materials, or advanced diagnostic tools rely on quality, well-characterized intermediates. 5-Chloro-2-Fluorobenzyl Bromide fits this bill, offering more than just a shortcut—it becomes a partner for creative problem-solving, efficient route design, and scientifically meaningful innovation. The next time a synthetic problem seems unsolvable, it’s worth checking whether a molecule like this can help. A single smart substitution often does more than a dozen workarounds.